Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PAVmed (PAVM) Revenue (2021 - 2025)

PAVmed has reported Revenue over the past 5 years, most recently at $81000.0 for Q4 2025.

  • For Q4 2025, Revenue rose 710.0% year-over-year to $81000.0; the TTM value through Dec 2025 reached $100000.0, down 96.72%, while the annual FY2025 figure was $100000.0, 96.66% down from the prior year.
  • Revenue for Q4 2025 was $81000.0 at PAVmed, up from $5000.0 in the prior quarter.
  • Over five years, Revenue peaked at $1.0 million in Q4 2023 and troughed at $5000.0 in Q3 2025.
  • A 5-year average of $339250.0 and a median of $177500.0 in 2022 define the central range for Revenue.
  • Biggest five-year swings in Revenue: soared 940.79% in 2023 and later tumbled 99.39% in 2025.
  • Year by year, Revenue stood at $300000.0 in 2021, then crashed by 62.67% to $112000.0 in 2022, then skyrocketed by 836.61% to $1.0 million in 2023, then plummeted by 99.05% to $10000.0 in 2024, then surged by 710.0% to $81000.0 in 2025.
  • Business Quant data shows Revenue for PAVM at $81000.0 in Q4 2025, $5000.0 in Q3 2025, and $6000.0 in Q2 2025.